Lv51
821 积分 2023-06-26 加入
Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study
1个月前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
2个月前
已完结
Axillary Surgery in Breast Cancer — Primary Results of the INSEMA Trial
2个月前
已完结
Large Language Models May Struggle to Detect Culturally Embedded Filicide-Suicide Risks
2个月前
已完结
China made waves with Deepseek, but its real ambition is AI-driven industrial innovation
2个月前
已完结
China’s cheap, open AI model DeepSeek thrills scientists
2个月前
已完结
Chinese firm’s large language model makes a splash
2个月前
已完结
Scientists flock to DeepSeek: how they’re using the blockbuster AI model
2个月前
已完结
How China created AI model DeepSeek and shocked the world
2个月前
已完结
Daily briefing: The pros and cons of DeepSeek
2个月前
已完结
皖公网安备34019202002308
